Nucleoside - PDFSEARCH.IO - Document Search Engine

Nucleoside
Results: 353

#	Item
91	12th Invitation to manufacturers and suppliers of medicinal products for HIV infection and related diseases, including treatment for hepatitis B and C, to submit an Expression of Interest (EOI) for product evaluation to Add to Reading List Source URL: apps.who.int Language: English - Date: 2014-09-18 04:42:10 Gilead Sciences Organofluorides Cyclopropanes Bristol-Myers Squibb Non-nucleoside reverse transcriptase inhibitors Lamivudine Efavirenz Tenofovir/emtricitabine Emtricitabine/tenofovir/efavirenz Chemistry Organic chemistry Pharmacology
92	SOGC CLINICAL PRACTICE GUIDELINE No. 310, August 2014 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission Add to Reading List Source URL: sogc.org Language: English - Date: 2014-09-25 08:34:19 HIV/AIDS Cyclopropanes Fixed dose combination Gilead Sciences Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug AIDS HIV Efavirenz Chemistry Medicine Organic chemistry
93	FDA Patient Safety News: Show #38, April 2005 Add to Reading List Source URL: www.fda.gov Language: English Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Pyridines Lactams Nevirapine Food and Drug Administration Adverse event Antiretroviral drug Off-label use Chemistry Pharmacology Organic chemistry
94	Microsoft Word[removed]Adult ART Guidelines Add to Reading List Source URL: www.fidssa.co.za Language: English - Date: 2010-09-29 05:18:06 HIV/AIDS Microbiology Antibiotic-resistant bacteria Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug Extensively drug-resistant tuberculosis Tuberculosis treatment AIDS Tuberculosis Medicine Health
95	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-08-21 15:16:08 Non-nucleoside reverse transcriptase inhibitors Pyridines Carbamates Sulfonamides Darunavir Lopinavir/ritonavir Etravirine Ritonavir Atazanavir Chemistry Organic chemistry Protease inhibitors
96	) . ., RCG Analysis – CNAA2007 Resistance Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-10-29 04:20:02 Cyclopropanes Medicine Carbamates Organofluorides Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug Efavirenz Viral load Reverse-transcriptase inhibitor HIV/AIDS Chemistry Organic chemistry
97	1 1 Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-10-27 10:32:13 HIV/AIDS Cyclopropanes Purines Non-nucleoside reverse transcriptase inhibitors Lactams Nevirapine Zidovudine Antiretroviral drug HIV Medicine Health Chemistry
98	PDF Document Add to Reading List Source URL: media.wiley.com Language: English - Date: 2013-08-22 16:17:40 Genetics RNA Nucleoside phosphoramidite Protecting groups Total synthesis Oligonucleotide synthesis Solid-phase synthesis Silyl ether Phosphoramidite Chemistry Organic chemistry Chemical synthesis
99	V Contents List of Contributors XIII Preface XVII A Personal Foreword XIX Add to Reading List Source URL: www.wiley-vch.de Language: English - Date: 2009-12-13 21:03:07 Cell biology ATP-binding cassette transporter P-glycoprotein ABCB11 Membrane transport protein Nucleoside transporter Neurotransmitter transporter Multidrug resistance-associated protein 2 Transmembrane protein ABC transporters Biology Membrane biology
100	HIGHLIGHTS OF PRESCRIBING INFORMATION ----------------------DOSAGE FORMS AND STRENGTHS--------------------• Tablet: 600-mg tablets supplied in 30-count bottles[removed]These highlights do not include all the informati Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:51:21 Organic chemistry Organofluorides Pharmacology Telbivudine Hepatitis B Nucleoside analogue Norfloxacin Lamivudine Antivirals Nucleosides Chemistry

UPDATE